Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4572695014 | Vaccine product containing only Human alphaherpesvirus 3 recombinant surface glycoprotein E antigen (medicinal product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 4572696010 | Recombinant Varicella-zoster glycoprotein E vaccine | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4576541013 | Human alphaherpesvirus 3 recombinant surface glycoprotein E antigen only vaccine product | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vaccine product containing only Human alphaherpesvirus 3 recombinant surface glycoprotein E antigen (medicinal product) | Plays role | Active immunity stimulant role | true | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only Human alphaherpesvirus 3 recombinant surface glycoprotein E antigen (medicinal product) | Is a | Vaccine product containing only Human alphaherpesvirus 3 antigen (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only Human alphaherpesvirus 3 recombinant surface glycoprotein E antigen (medicinal product) | Has active ingredient | Antigen of Human alphaherpesvirus 3 recombinant surface glycoprotein E | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR